Infant 25% DEXTROSE Injection, USP, 2.5 g (250 mg/mL), 10 mL Unit of Use Single- Supply Disruption — Hospira Inc. (High Risk — Ser
Infant 25% DEXTROSE Injection, USP, 2.5 g (250 mg/mL), 10 mL Unit of Use Single- Supply Disruption — Hospira Inc. (High Risk — Ser is one of 9,000 drug supply records in the DrugSupply dataset. Key details — Drug name: Infant 25% DEXTROSE Injection, USP, 2.5 g (250 mg/mL), 10 mL Unit of Use Single-; Manufacturer: Hospi
| Drug name | Infant 25% DEXTROSE Injection, USP, 2.5 g (250 mg/mL), 10 mL Unit of Use Single- |
|---|---|
| Manufacturer | Hospira Inc. |
| Recall/Disruption reason | Presence of Particulate Matter: human hair found within an internal sample syringe. |
| Risk classification | High Risk — Serious Health Hazard |
| Status | Ongoing |
| Record type | Enforcement/Recall |
| Recall number | D-0862-2017 |
| Initiation date | 20170421 |
| Quantity affected | 71,550 syringes |
| Dosage form | Drugs |
🔍 Search all drug supply records →
$1199/mo
Try DrugSupply →